Literature DB >> 8586724

Amplification of Mycobacterium tuberculosis from peripheral blood.

A Rolfs1, J Beige, U Finckh, B Köhler, T Schaberg, J Lokies, H Lode.   

Abstract

To determine the value of the PCR assay of lymphomonocytic blood cells for the diagnosis of pulmonary tuberculosis, we compared, in a prospective study, PCR results with results of conventional diagnostic methods of Mycobacterium tuberculosis detection. Clinical investigators who were unaware of the PCR data classified 162 immunocompetent patients, who had been hospitalized because of suspected pulmonary tuberculosis, in accordance with the recommendations of the American Thoracic Society (ATS). By testing blood samples from these patients for mycobacterial DNA with three different PCR systems, we were able to demonstrate that nonquantitative PCR of peripheral blood leukocytes is of little value for the specific diagnosis of pulmonary tuberculosis. However, semiquantitative PCR assays might have some significance since we found an increasing level of mycobacterial DNA copies in blood from patients classified in ATS groups 2 to 5.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586724      PMCID: PMC228695          DOI: 10.1128/jcm.33.12.3312-3314.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis.

Authors:  K D Eisenach; M D Cave; J H Bates; J T Crawford
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

2.  Rapid, simple method for treating clinical specimens containing Mycobacterium tuberculosis to remove DNA for polymerase chain reaction.

Authors:  G E Buck; L C O'Hara; J T Summersgill
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction.

Authors:  P W Hermans; A R Schuitema; D Van Soolingen; C P Verstynen; E M Bik; J E Thole; A H Kolk; J D van Embden
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products.

Authors:  P N Rys; D H Persing
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

5.  Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis.

Authors:  N W Schluger; R Condos; S Lewis; W N Rom
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

6.  Detection of Mycobacterium tuberculosis in peripheral blood.

Authors:  A H Kolk; L F Kox; S Kuijper; C Richter
Journal:  Lancet       Date:  1994-09-03       Impact factor: 79.321

7.  Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories.

Authors:  G T Noordhoek; A H Kolk; G Bjune; D Catty; J W Dale; P E Fine; P Godfrey-Faussett; S N Cho; T Shinnick; S B Svenson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

8.  Rapid diagnosis of tuberculous meningitis by polymerase chain reaction.

Authors:  P Shankar; N Manjunath; K K Mohan; K Prasad; M Behari; G K Ahuja
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

9.  A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples.

Authors:  L F Kox; D Rhienthong; A M Miranda; N Udomsantisuk; K Ellis; J van Leeuwen; S van Heusden; S Kuijper; A H Kolk
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Clinical evaluation of a Mycobacterium tuberculosis PCR assay.

Authors:  J Beige; J Lokies; T Schaberg; U Finckh; M Fischer; H Mauch; H Lode; B Köhler; A Rolfs
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

  10 in total
  8 in total

1.  Determination of the etiology of presumptive feline leprosy by 16S rRNA gene analysis.

Authors:  M S Hughes; N W Ball; L A Beck; G W de Lisle; R A Skuce; S D Neill
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens.

Authors:  U Reischl; N Lehn; H Wolf; L Naumann
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 3.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  PCR-based rapid detection of Mycobacterium tuberculosis in blood from immunocompetent patients with pulmonary tuberculosis.

Authors:  N Ahmed; A K Mohanty; U Mukhopadhyay; V K Batish; S Grover
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis.

Authors:  Shiyang Pan; Bing Gu; Hong Wang; Zihe Yan; Peng Wang; Hao Pei; Weiping Xie; Dan Chen; Genyan Liu
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

6.  Detection of Mycobacterium tuberculosis in blood by use of the Xpert MTB/RIF assay.

Authors:  Padmapriya P Banada; Ranie Koshy; David Alland
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

7.  A proof of concept study to assess the potential of PCR testing to detect natural Mycobacterium bovis infection in South American camelids.

Authors:  Timothy R Crawshaw; Jeremy I Chanter; Adrian McGoldrick; Kirsty Line
Journal:  Ir Vet J       Date:  2014-02-07       Impact factor: 2.146

8.  Comparison of in-house PCR with conventional techniques and Cobas Amplicor M. tuberculosis kit for detection of Mycobacterium tuberculosis.

Authors:  Myeong-Hee Kim; Hee-Young Yang; Jin-Tae Suh; Hee Joo Lee
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.